Literature DB >> 18592835

Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema.

David H Dreyfus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18592835     DOI: 10.1016/S1081-1206(10)60069-5

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  5 in total

Review 1.  What to do with refractory urticaria patients.

Authors:  Allen P Kaplan
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

Review 2.  Biologic agents in the treatment of urticaria.

Authors:  Allen P Kaplan
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

Review 3.  Serological evidence that activation of ubiquitous human herpesvirus-6 (HHV-6) plays a role in chronic idiopathic/spontaneous urticaria (CIU).

Authors:  D H Dreyfus
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

4.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

5.  Eosinophils in chronic urticaria: supporting or leading actors?

Authors:  Riccardo Asero; Massimo Cugno; Alberto Tedeschi
Journal:  World Allergy Organ J       Date:  2009-09       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.